The bill establishes two significant entities within the University of South Florida aimed at advancing research and care for Parkinson's disease. The first entity is the Consortium for Parkinson's Disease Research, which will consist of public and private universities and academic medical centers. This consortium will be directed by the Parkinson's Disease Research Board, responsible for overseeing operations, adopting an annual research plan, and issuing reports to the Governor and Legislature. The board will also award funds for research aligned with the plan, which focuses on understanding the causes, mechanisms, and potential treatments for Parkinson's disease, as well as its prevalence among first responders.

The second entity created by the bill is the Florida Institute for Parkinson's Disease, which will serve as a statewide resource for research and clinical care. Its primary purpose is to find a cure for Parkinson's disease and enhance the quality of life for those affected by it through improved knowledge, diagnosis, and treatment. The bill emphasizes the importance of innovative research in addressing the challenges posed by Parkinson's disease, which currently affects approximately one million Americans. The provisions of the bill will be implemented as funding becomes available in the General Appropriations Act, and it is set to take effect on July 1, 2025.